[HTML][HTML] Low-dose gefitinib treatment for patients with advanced non-small cell lung cancer harboring sensitive epidermal growth factor receptor mutations

H Satoh, A Inoue, K Kobayashi, M Maemondo… - Journal of Thoracic …, 2011 - Elsevier
Introduction Although standard schedule of gefitinib was the administration of 250 mg tablet
every day, many patients need dose reduction because of toxicities. However, the efficacy of …

[引用][C] Low-Dose Gefitinib Treatment for Patients with Advanced Non-small Cell Lung Cancer Harboring Sensitive Epidermal Growth Factor Receptor Mutations

H Satoh, A Inoue, K Kobayashi, M Maemondo… - Journal of Thoracic …, 2011 - cir.nii.ac.jp
Low-Dose Gefitinib Treatment for Patients with Advanced Non-small Cell Lung Cancer
Harboring Sensitive Epidermal Growth Factor Receptor Mutations | CiNii Research CiNii 国立 …

Low-dose gefitinib treatment for patients with advanced non-small cell lung cancer harboring sensitive epidermal growth factor receptor mutations

H Satoh, A Inoue, K Kobayashi… - Journal of Thoracic …, 2011 - tohoku.elsevierpure.com
Although standard schedule of gefitinib was the administration of 250 mg tablet every day,
many patients need dose reduction because of toxicities. However, the efficacy of such low …

Low-dose gefitinib treatment for patients with advanced non-small cell lung cancer harboring sensitive epidermal growth factor receptor mutations.

H Satoh, A Inoue, K Kobayashi… - Journal of Thoracic …, 2011 - europepmc.org
Methods A post hoc comparison of the efficacy (response rate and survival) in patients
treated with gefitinib with or without any dose reduction in NEJ002 study was performed …

Low-dose gefitinib treatment for patients with advanced non-small cell lung cancer harboring sensitive epidermal growth factor receptor mutations

H Satoh, A Inoue, K Kobayashi… - Journal of thoracic …, 2011 - pubmed.ncbi.nlm.nih.gov
Introduction Although standard schedule of gefitinib was the administration of 250 mg tablet
every day, many patients need dose reduction because of toxicities. However, the efficacy of …

[PDF][PDF] Low-Dose Gefitinib Treatment for Patients with Advanced Non-small Cell Lung Cancer Harboring Sensitive Epidermal Growth Factor Receptor Mutations

H Satoh, A Inoue, K Kobayashi, M Maemondo… - Journal of Thoracic …, 2011 - core.ac.uk
Introduction: Although standard schedule of gefitinib was the administration of 250 mg tablet
every day, many patients need dose reduction because of toxicities. However, the efficacy of …

Low-Dose Gefitinib Treatment for Patients with Advanced Non-small Cell Lung Cancer Harboring Sensitive Epidermal Growth Factor Receptor Mutations

H Satoh, A Inoue, K Kobayashi, M Maemondo… - Journal of Thoracic …, 2011 - jto.org
Introduction Although standard schedule of gefitinib was the administration of 250 mg tablet
every day, many patients need dose reduction because of toxicities. However, the efficacy of …